Market Alert: Strong Nuclear Tensions in South Asia Assessing the Fallout on Global Equity Markets
Life insurance advisers who neglect to review legacy policies may face scrutiny from the Financial Markets Authority (FMA), warns Compliance Refinery director Steven Burgess. Speaking at a Quotemonster event, Burgess emphasized that legacy policies—older insurance products no longer open to new customers—must be carefully evaluated. Advisers risk regulatory action if they fail to assess whether these older policies still meet clients' needs. Burgess highlighted the importance of thorough record-keeping, personalized advice, and utilizing available tools like CRM software and Quotemonster’s research on legacy products. He stressed that documenting both the pros and cons of policy changes is crucial to avoid regulatory issues.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 28, 2025
Apr 28, 2025
Apr 24, 2025
Apr 24, 2025
Apr 23, 2025
Apr 14, 2025
Apr 11, 2025
Apr 11, 2025
Apr 10, 2025
Apr 10, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is based in Australia. The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.